Home » Topics » Regulatory » Patents

Patents
RSS

Minghui Pharmaceutical discovers nucleoside derivatives

Aug. 14, 2020

Yumanity Therapeutics identifies stearoyl-CoA desaturase 1/5 inhibitors

Aug. 13, 2020

Merck KGaA discovers dual adenosine A2A/A2B receptor antagonists

Aug. 13, 2020

Novartis presents NLRP3 inflammasome inhibitors

Aug. 13, 2020

G protein-coupled receptor 35 modulators discovered at Precision IBD

Aug. 13, 2020

Daiichi Sankyo describes new SIRT6 activators

Aug. 13, 2020

5'-nucleotidase inhibitors discovered by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Aug. 12, 2020

Ascentage Pharma, University of Michigan patent Mcl-1 inhibitors

Aug. 12, 2020

Camphor Pharmaceuticals synthesizes new prostanoid EP4 receptor antagonists

Aug. 12, 2020

New NLRP3 inflammasome inhibitors discovered at NodThera

Aug. 12, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...